Skip to main content
Table of Contents
Print

Does Cannabis’ THC Make Anxiety Worse in People with Panic Disorder? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

THC is a common cannabinoid in cannabis, but patients with panic disorder often wonder if THC’s panic disorder anxiety could worsen their symptoms. While some individuals may experience calming effects, research shows that THC can sometimes trigger symptom worsening, including increased heart rate, racing thoughts, and heightened fear. Evaluating THC’s panic disorder anxiety is essential to understand potential adverse effects and the overall risk profile before use. 

Understanding THC’s Impact on Anxiety 

Professional guidance is crucial when considering THC’s panic disorder anxiety effects. Knowing the potential adverse effects helps patients make informed choices and avoid unexpected symptom worsening. 

Adverse Effects 

THC may cause increased anxiety, panic sensations, or paranoia, particularly in sensitive individuals. 

Symptom Worsening 

Patients should monitor for symptom worsening such as rapid heartbeat or heightened fear, which can complicate panic disorder management. 

Risk Profile 

Understanding the risk profile of THC, including personal sensitivity and dosage considerations, is essential for safe use in panic disorder. 

In conclusion, THC’s panic disorder anxiety effects vary between individuals, and professional supervision is essential to minimise risks and ensure safe use. 

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories